From March 10, 2022 to June 30, 2022, the company has repurchased 3,620,000 shares, representing 0.5% for CNY 27.3 million. With this, the company has completed the repurchase of 3,620,000 shares, representing 0.5% for CNY 27.3 million under the buyback announced on March 10, 2022.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
4.99 CNY | -1.58% | +1.63% | -9.76% |
1st Jan change | Capi. | |
---|---|---|
-9.76% | 48Cr | |
+15.91% | 4.2TCr | |
+22.40% | 2.23TCr | |
+18.48% | 1.52TCr | |
+16.12% | 1.4TCr | |
+45.12% | 1.21TCr | |
-9.58% | 679.6Cr | |
-0.05% | 678.76Cr | |
-8.87% | 572.55Cr | |
+14.18% | 549.33Cr |
- Stock Market
- Equities
- 603669 Stock
- News Lionco Pharmaceutical Group Co.,Ltd.
- Tranche Update on Lionco Pharmaceutical Group Co.,Ltd.'s Equity Buyback Plan announced on March 10, 2022.